Mapfre

COVID-19 fragility

26/03/20 -"The reduction in our target price was driven by lower earnings for 2020-22 and the increase in the discount, attributed to P/Book, P/E and dividend yield relative to its peers, from 20% to 40%. This ..."

PDF page sample
Pages
50
Language
English
Published on
26/03/20
Download
You may also be interested by these reports :
05/03/26
In FY25, Ageas’s underlying operating results were broadly in line with expectations. The group’s net operating result came in at €1.65bn (+33% y/y). ...
05/03/26
We have incorporated Scor’s FY25 results and revised our assumptions upward for 2026 and the subsequent years. Scor’s Q4 results were ahead of ...
04/03/26
Scor’s 4Q25 results came in above expectations, with strong underlying trends in both business lines and robust capital generation. The outlook is ...
03/03/26
AXA delivered a strong set of FY25 results, with resilient top-line growth and margins, despite a more competitive environment in P&C Commercial ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO